Category: NYSE:CVS

California Clears CVS-Aetna Deal After Concession To ‘Not Increase Premiums’

A California regulator Thursday cleared CVS Health’s acquisition of Aetna, securing a commitment to “not increase premiums as a result of the acquisition.”

Humana CEO: ‘We’ll Continue To Build’ Walgreens, Walmart Relationships

Humana’s relationships with Walgreens Boots Alliance and Walmart to establish closer ties with national retail healthcare providers is going well, Humana CEO Bruce Broussard said.

CVS Says Aetna Deal Will Close By Thanksgiving

CVS Health said the acquisition of Aetna will close by Thanksgiving, which is in two weeks, CVS CEO Larry Merlo said Tuesday.

Anthem’s PBM On Track for 2020 Launch

Anthem said its own pharmacy benefit manager, IngenioRx, “remains on track” to launch Jan. 1, 2020.

Aetna Reports $1B Profit As Sale To CVS Health Nears Closing

Aetna reported $1 billion in the third quarter profits as the insurer prepares to be taken over by drugstore giant CVS Health.

Rite Aid’s CEO And Board Face Confidence Vote Next Week

Rite Aid’s board and CEO face an uncertain vote from shareholders Tuesday when a new board slate is voted on Tuesday, Oct. 30 at the company’s annual meeting in New York.

Centene Rolls Out RxAdvance PBM Promising Drug Cost Transparency

Centene has begun rolling out its new relationship with the pharmacy benefit manager, RxAdvance, a cloud-based PBM.

Opioid Lawsuits On Par To Become Largest Civil Litigation Agreement In U.S. History

Recent months have seen a surge in opioid-related lawsuits against pharmaceutical companies and individual leadership of pharma, as well as retail pharmacies and dispensaries. Interestingly, they are being filed by cities, counties, state’s attorneys g…

Walgreens To Expand Primary Care With Michigan Health System

Walgreens Boots Alliance will collaborate with Michigan’s McLaren Health Care to expand primary healthcare services throughout the state.

UnitedHealth Group’s Value-Based Care Spend Hits $69 Billion

UnitedHealth Group says it’s paying almost half of its reimbursements – or $69 billion – via value-based care models.